BOULDER, Colo. -- (Business Wire)
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J.
Mahaffy, Chief Executive Officer and President, will present at the 16th
Annual Morgan Stanley Global Healthcare Conference on Thursday,
September 13, 2018 at 2:55 PM Eastern Time. The conference will be held
at the Grand Hyatt New York in New York City.
A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools that direct a compound in development to the population that is
most likely to benefit from its use. Clovis Oncology is headquartered in
Boulder, Colorado, and has additional offices in San Francisco,
California and Cambridge, UK. Please visit www.clovisoncology.comfor more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180906005129/en/
Anna Sussman, 303-625-5022
Source: Clovis Oncology
© 2019 Canjex Publishing Ltd. All rights reserved.